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Abstract
In the present paper, we investigate the biological performance of the tricalcium phos-
phate ceramic (β-TCP) bone substitute combined with the fluorapatite (Fap). Porous 
biocomposites consisting of β-tricalcium phosphate (β-TCP) with 26.5% fluorapatite 
(Fap) were elaborated and characterized in order to evaluate its potential applica-
tion in bone graft substitute. Bioactivity was determined with in vivo and in vitro tests 
by immersion of samples in simulated fluid body (SBF) for several periods of time. 
Clinical, radiological, and histological assessments were then carried out to evalu-
ate the biological properties of developed β-TCP-26.5% Fap composites. An in vivo 
investigation revealed the biological properties of the prepared macroporous scaffolds, 
namely, biocompatibility, bioactivity, biodegradability, and osteoconductivity. The 
morphological characteristics, granule size, and chemical composition were indeed 
found to be favorable for osseous cell development. All histological observations of 
the preliminary in vivo study in the tibia of rabbits proved the biocompatibility and 
the resorption of the investigated bioceramic. In contrast, the implantation period will 
have to be optimized by further extensive animal experiments.
Keywords: bone substitute, tissue engineering, bioceramic, tricalcium phosphate, in vivo, 
in vitro, implant
1. Introduction
Tissue engineering applies methods from materials engineering and life sciences to create 
artificial constructs for regeneration of new tissue. Even though a range of tissues has been 
studied, the translation of engineered tissues to clinical applications has been limited [1]. 
Researchers in bone tissue engineering are working to develop alternatives to allogenic and 
© 2017 The Author(s). Licensee InTech. This chapt r is distributed under the terms of the Creative Comm s
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autologous bone grafts in order to address the growing needs of the population, and much of 
the research is scaffold based [2–7].
Calcium phosphate ceramics have been extensively used to produce porous scaffolds due 
to their bone-like chemical composition as well as excellent biological properties, includ-
ing biocompatibility and osteoconductivity [8–11]. The use of these bioceramics was always 
restricted because of its fragility and the weak rupture resistance [12]. Hence, there was 
a need for maximizing mechanical properties of tricalcium phosphate β-TCP suitable for 
orthopedic applications. In recent investigation, a β-TCP-fluorapatite (Fap) composite has 
been developed for biomedical applications [13]. These β-TCP-Fap have shown a good com-
bination of compressive strength (95 MPa), flexural strength (15 MPa), and fracture tough-
ness (2.9 MPa m1/2) [14]. Pure fluorapatite is known to possess a potential advantage with its 
high chemical stability and aptitude to delay caries’ process without the biocompatibility 
degradation [15]. In addition, it has a much lower solubility in biological fluid than hydroxy-
apatite. In several studies, it has been proved that the amount of the released fluoride ions F− 
affects directly cell attachment, proliferation, morphology, and differentiation of osteoblast 
cells [16, 17]. It is known that the fluorine ion itself enhances mineralization and crystalliza-
tion [17]. Since such bioceramic β-TCP-26.5% wt% Fap composition has never been investi-
gated in vitro and in vivo response as bone substitute. Among various properties, biological 
response of the developed composites should be evaluated in the light of its potential used 
in tissue engineering. It worth to note that all newly developed biomaterials are subjected 
to be approved based on their in vivo response results. In fact, in vitro experiments cannot 
produce significant evidences toward the biocompatibility of the investigated materials due 
to the absence of several hormones and enzymes [18].
In view of the above, the aim of this study is to investigate the bioactivity response of the new 
biphasic ceramic in vitro in simulated fluid body (SBF) and to evaluate its biocompatibility 
and also the process of bone regeneration in rabbits. The clinical, radiological, and histological 
assessments were performed.
2. Materials and methods
2.1. Materials
In order to elaborate β-TCP-Fap composites, the used materials are the commercial trical-
cium phosphate (Fluka) and synthesized fluorapatite. The Fap powder was synthesized 
by the precipitation method [19]. In order to improve the biocompatibility of the fluor-
apatite and the strength of tricalcium phosphate effectively and to search for an approach 
to produce high performances of the tricalcium phosphate-fluorapatite ceramics. In this 
study, Fap has been used with a fixed 26.5 wt% amount because the human bone contains 
1 wt% of fluorine approximately [20]. Estimated quantities of each powder were milled 
with absolute ethanol and treated by ultrasound machine for 20 min. The milled powder 
was dried in a low temperature oven at 80°C to eliminate the ethanol and generate a finely 
divided powder.
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The sintered samples used in in vitro study [21] were prepared using a molding process to 
form pellets of 10 mm ϕ × 2 mm of thickness (Figure 2a). The details of process optimization, 
density value, and microstructure could be found elsewhere [22]. All the samples used in the 
study had almost the same surface area and volume. It is worth noting that the experiments 
were repeated at least three times. At the end of experiments, all the samples were charac-
terized by various technical tools. Scanning electron microscopy (SEM) was done to reveal 
the changes in topographical features and to visualize calcium phosphate crystals, the final 
products for the β-TCP-Fap reaction.
In order to obtain three-dimensional bioceramic for the in vivo evaluation, the β-TCP-26.5% 
Fap samples were prepared using polymeric sponge replication method [23–27]. This tech-
nique is based on the reproduction of a polymer foam with open cells by impregnation of a 
ceramic slurry and removing the support by thermal treatment (Figure 1b). This later was 
optimized based on thermal analysis [28]. Based on previous studies [13], the composite 
samples were sintered at 1300°C for 90 nm. Helium porosimetry and the Archimedes method 
were used for investigating density and porosity (both open and closed) of sintered samples.
The mechanical strength of the obtained macroporous biphasic ceramic β-TCP-26.5% Fap was 
also determined by Lloyd testing machine. The specimens used for compression test were 
prepared into cylinders (9.0 mm in diameter and 18.0 mm in length) as instructed in ASTM 
standards C1424-15.
Figure 1. Photograph of the tested specimens: (a) for in vitro tests and (b) for in vivo tests.
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2.2. Scanning electron microscopy
The microstructure of the sintered samples was observed by scanning electronic microscopy 
(SEM) (JSM-5400). The observations were performed on gold-coated specimens and investi-
gated at an acceleration voltage of 15 kV for all samples.
2.3. In vitro bioactivity assessment in SBF
Bioactivity was checked through tests of immersion in simulated body fluid (SBF) [21]. In 
order to study the dissolution behavior of the β-TCP-Fap in physiological environment, the 
in vitro dissolution study was carried out by immersing batches of samples for six differ-
ent time periods of 4, 24, and 49 h and 6, 12, and 30 days. The initial pH of the solution was 
kept at 7.42 with tris(hydroxymethyl)-aminomethane and hydrochloric acid. The solution 
temperature was maintained at body temperature, i.e., 37°C using an incubator. 100 ml of 
SBF solution was used for each sample. The ion concentration of the SBF is shown in Table 1.
2.4. In vivo implantation experiments
2.4.1. Surgical procedures
Given the closeness of the metabolism of rabbit s to humans, we estimated that the resorption 
kinetics in rabbits can fairly be assumed to be similar to that in humans.
Figure 2. Digital camera images: (a and b) showing the implantation site and (c and d) β-TCP-26.5% Fap scaffold 
implanted inside the tibia of rabbit.
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In this experiment, two New Zealand white rabbits with an average weight of 2.1 kg were 
used. The β-TCP-26.5% Fap pellets were sterilized by irradiation from a 60Co gamma irradia-
tion source at a dose of 25 Gy (Equinox, UK) using standard procedures for medical devices. 
The surgical procedure earned approval from ethical committee of the Tunisian Association 
of Laboratory Animal Sciences according to the ICLAS ethical guidelines for researchers to 
committee. All animals were subject to general, backed with local, anesthesia through intra-
muscular administration of 10 mg/kg ketamine hydrochloride (Ketaminol®, Germany) and 
0.1 mg/kg xylazine (Rompun®, France).
In each animal, one lower limb was prepared aseptically for surgery. After shaving the lower 
limb segment and disinfecting it with Betadine®, a 4 cm skin incision was made medially over 
the leg, and the tibia was exposed subperiosteally. A 10 mm bony segmental defect was then 
created by two osteotomies in the middle portion of the tibia. The osteotomy was performed 
with an oscillating saw at a right angle to the axis of the bone. The defect was then filled with a 
suitably shaped bioceramic (Figure 2(a–d)). To stabilize the tibia and maintain a direct contact 
between bioceramic and the bone, a mini-stainless steel monoplanar fixator was used. Four pins 
were inserted through the skin into the bone and then attached to a steel rod outside the limb. 
Next, the wound was closed for the periosteum and the subcutaneous tissues using a resorbable 
suture. Finally, a postoperative bandage was made with a sterile compress after local applica-
tion of Betadine gel®. After the surgical procedure, all the animals were given postoperative care.
Radiographic images were taken at 4 days, 6 weeks, and 12 weeks after implantation to assess 
the stability of the bioceramic and follow the general structural health of the operated bone; 
anteroposterior and lateral radiographs of each operated leg were made. Radiographs were 
obtained using an X-ray machine.
2.4.2. Histological evaluation
For microscopic evaluation and to evaluate composite biocompatibility and the biological 
response of the bone tissue in contact, histological studies were conducted after 12 postoperative 
Ion Concentration (mmol/l)
SBF Human plasma
Na+ 142.0 142.0
K+ 5.0 5.0
Mg2+ 1.5 1.5
Ca2+ 2.5 2.5
Cl− 103.0 147.8
HCO3− 27.0 4.2
HPO
4
2− 1.0 1.0
SO
4
2− 0.5 0.5
pH 7.2–7.4 7.4
Table 1. Ion concentrations of the human blood plasma and the SBF solution.
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weeks. The animals were euthanized, and then the sites of implantations were grossly exam-
ined for any evidence of tissue reaction, and tibia bones with the test implant materials were 
removed and fixed in 10% formaldehyde during 24 h to immobilize the cells for subsequent 
histological studies. The timing was selected to assess the performance of the biomaterial bone 
formation before degradation. The samples were then dehydrated in three successive acetone 
baths. Next, they were placed in methyl methacrylate (MMA) with decalcification. Sections of 
4 μm thick were debited along a transverse plane using a sliding microtome (Reichert-Jung). 
Once colored with hematoxylin eosin, the cut was mounted between slide and slip cover. The 
colored cuts were observed through a binocular microscope (Olympus® CX-21i), and the obser-
vations were photographed with various magnifications using the digital camera.
3. Results and discussion
3.1. Bioactive surface characterization (in vitro test): SEM results
To investigate the dissolution behavior of the samples, SEM was performed. It has been seen 
(Figure 3b) that the surface of soaked sample becomes more porous after 4 h immersion, 
which is a signature that dissolution has occurred. The dissolution affects the strength by 
Figure 3. SEM micrographs: (a) sintered β-TCP-26.5% Fap before immersion in SBF, (b) development of porous regions 
after 4 h of dissolution process, (c) nucleation of apatite crystals after 24 h, and (d) pores filled with formed apatite after 48 h.
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increasing the porosity and weakening the grain boundary. After 24 h immersion, the micro-
structural observation indicates that the surfaces of grains appear mottled.
SEM (Figure 3c) indicates precipitation of nodular apatite on the biocomposite grains. With the 
increase in immersion time, the quantity and size of these apatite particles increase gradually. 
We note the formation of apatite agglomerate. The apatite formation fills the pores and increases 
the density and strength of the material (Figure 3d). Moreover, EDS analysis also performed on 
the surface of the soaked sample revealed the presence of calcium and phosphorous elements 
on the surface, with Ca-P equal to 1.67. This Ca-P ratio is in accordance to stoichiometric bio-
logical apatite and indicated that the deposit form during SBF conditioning is apatite layer.
SEM images depict the change in the topographical features recorded for various time intervals 
during experiment. In fact, the precipitation is more prevalent after immersion showing the for-
mation of bone-like apatite layer due to the dissolution of Ca2+ and PO
4
3−, followed by deposition 
of Ca-P (Figure 4a). Higher magnification SEM micrograph reveals that particles of apatite grow 
in a flake-like form and many of these formed agglomerates on the surface of sample (Figure 4c). 
After soaking for 12 days, in the surface of sample, tiny ball apatite particles that formed porous 
agglomerates were found (Figure 5b and c). This outcome has been found by previous studies 
that proved that the apatite formation occurs in two stages: a formation of globular particles fol-
lowed by appearance of aggregate which joined together to form a covering layer [29].
Figure 4. SEM images show the topographic features of β-TCP-26.5% Fap sample after 6 days of dissolution period, 
(b) is a magnified image of a selected zone from (a), and (c) apatite grows in a flake-like form.
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After 30 days of immersion in SBF, a thick and dense mineral layer was formed on the spec-
imen surface, and mineral crystals covered almost the surface of the specimen. Figure 6b 
reveals higher magnification micrograph of the region marked in Figure 6a showing typical 
entanglement of the reprecipitated leaf-like or plate-like crystals (Figure 6c).
It is well known that the dissolution of the initial Ca-P compounds has occurred until the 
oversaturation of the solution, thus inducing the reprecipitation of crystals [10, 30]. The bioac-
tivity of calcium phosphate and other materials has been related to their propensity to nucle-
ate apatite crystals [31]. The presence of bone-like apatite agglomerate on the surface of any 
implant is always considered as a positive biological response. Therefore, the findings that 
β-TCP-26.5% Fap shows extensive precipitation of apatite are a clear indication of bioactivity.
3.2 Preliminary in vivo evaluation
3.2.1. Microstructure and mechanical characterization of bioceramic scaffolds
The SEM analysis for β-TCP-26.5% Fap scaffolds presented highly porous and interconnective 
pore architecture with porosity of 75% which has an open porosity 71%. As can be observed in 
Figure 7, the ceramic foams appeared to be macroporous with different pore sizes. The pore 
size distribution seemed to be uniform. Pore sizes were roughly about 300 μm, which is above 
the critical value of 100 μm to allow bone [32].
Figure 5. SEM micrographs of sample surface after 12 days of immersion (a) showed the deposit apatite layer, (b) porous 
agglomerates of apatite particles, and (c) needle-like apatite crystals.
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The mechanical strength of the β-TCP-26.5% sintered foam was plotted as function of poros-
ity (Figure 8). At least six samples were tested under compression test condition. Average 
strength values were calculated. The maximum error obtained was found to be less than 5%. 
As expected, the compressive strength decreased with increasing porosity. Moreover, the 
compressive strength presented a sharp decrease as soon as macropores are introduced.
Figure 6. SEM images of β-TCP-26.5% Fap sample after soaking in SBF for 30 days: (a) joined aggregate forms a covering 
layer, (b) showing needle-like and plate-like crystals, and (c) is a magnified image of selected zone from (b).
Figure 7. (a) SEM images of porous β-TCP-26.5% Fap and (b) zoom.
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3.2.2 Clinical control and radiological findings
During the postoperative, the daily clinical evaluation exhibited no sign of surgical site infec-
tion (i.e., swelling, redness, or wound disunion) on the operated rabbits, which had overcome 
the tibia osteotomy. After 6 weeks postimplantation, the radiographs showed healing of the 
host bone and mild degeneration of the implanted bioceramic. The bioresorption is partly 
revealed by the change in implant dimension (Figure 9b).
At 12 postoperative weeks, the radiograph showed complete healing of the host bone and 
disappearance of the implanted biomaterial (Figure 9c). In fact, bone consolidation was noted 
in the two rabbits.
3.2.3. Organ harvesting and general observations
After completion of the expected implantation time (12 postoperative weeks), the operated rab-
bits were sacrificed, and the samples were extracted immediately and then stored in an ethanol 
or BBS solution prior to the histological study. The explants were then transferred to the labora-
tory of histology and embryology for inclusion in resin and histological study. Given the small 
amount of data currently being processed, we cannot conclude on the osteoconductive potential 
of our implant. However, it should be noted that no major problems occurred during the opera-
tion or during the implementation periods. In addition, observation of the explants also showed 
almost complete dissolution of the elaborated implant and the formation of a new neoformed 
bone (Figure 10). This observation will be confirmed by the histological study.
3.2.4. Histological analysis
Although tricalcium phosphate and fluorapatite are reported to be biocompatible in vivo, 
the combination of these phases is not yet tested in vivo. Therefore, the biocompatibility 
Figure 8. Compressive strength versus open porosity of β-TCP-26.5% bioceramics.
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Figure 9. X-ray radiographs of postimplant rabbit’s tibia: (a) after 4 days, (b) after 6 postoperative weeks, and (c) after 
12 postoperative weeks.
Figure 10. Extraction of the implant after 12 postoperative weeks.
TCP-Fluorapatite Composite Scaffolds: Mechanical Characterization and In Vitro/In Vivo Testing
http://dx.doi.org/10.5772/intechopen.69852
139
evaluation of this biphasic material would be of great interest. It is to be noted here that in 
the investigated composite, the major phase is β-TCP, which is well known for its bioresorb-
ability. However, in our case, the resorption is limited due to the presence of second-phase 
fluorapatite.
Figure 11 illustrates the representative optical microscopy images of the histological sections 
of bone implant interface. A cellular infiltrate, predominantly composed of macrophages, 
was observed. Although the short-term implantation of 12 weeks is being carried out in 
this investigation, the experimental observations should provide clear indication about the 
biocompatibility in vivo. These findings revealed that β-TCP-26.5% Fap is biocompatible and 
appears to induce acceptable in vivo response. However, it appeared that the resorption rate 
of this bioceramic was far too low to induce neobone formation after 12 weeks postimplan-
tation. Despite these results, the proposed material presented markedly better mechanical 
properties than monophasic β-TCP [14]. Hence, the incorporated fluorapatite can be used 
to modulate the biological and the mechanical properties. Thus, the challenge is to find a 
balance between the biological performance and the changes in mechanical behavior pro-
voked by both the macroporosity and the composite effects. Further encouragement from 
these results is that the novel bioceramic should have an attracted potential as bioactive 
coating for orthopedic. Such application required long-term and sufficient mechanical sta-
bility when under physiological stresses associated with locomotion to not detach from the 
implant surface [33].
Considering the importance of the time required for integration and osteointegration, which 
is determined by the newly formed bone at the host bone-material interface, we should inves-
tigate the biological response according to ISO-10993 guidelines. Additionally, the implanta-
tion period will have to be optimized by further extensive animal experiments. An in vitro cell 
culture model can be also an alternative to study the cytocompatibility of the novel bioceramic 
as well as other research [34–36].
Figure 11. Histological sections of β-TCP-26.5% Fap scaffold after 12 weeks of implantation in rabbit. (A) Fibrous tissue 
surrounding the biomaterial. (B) Inflammatory infiltrates around degradated biomaterial ( ).
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4. Conclusion
In this study, a novel biphasic material that consisted of two major phases of tricalcium 
phosphate and fluorapatite was investigated. During bioactivity experiments, the bone sub-
stitute material exhibited to be able to produce porous apatite layer in vitro. The combina-
tion of dissolution and precipitation is found to be the mechanism of apatite formation. The 
results showed that fluoride released ion decreased the dissolution rate by improving the 
crystallization.
A preliminary in vivo investigation revealed that the new bioceramic scaffold with highly 
porous architecture exhibits biocompatibility. It can be concluded that β-TCP-26.5% Fap may 
take few more weeks for deposition of neobone. Besides, there are many aspects related to 
in vivo behavior that need further in vivo results in order to confirm or improve the formu-
lation of the porous bioceramic that should promote both osteoconductive and resorption 
processes.
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